Loading data for LIPO — first visit, this takes a few seconds.
Lipella Pharmaceuticals I... (LIPO)
OTC Markets OTCPK: LIPO
· Real-Time Price · USD
0.00
n/a (n/a)
At close: Aug 21, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Lipella Pharmaceuticals Inc. (LIPO) Stock Price, Analysis & Data
No data available
| Bid | 0.03 |
| Market Cap | 1.85K |
| Revenue (ttm) | 389.78K |
| Net Income (ttm) | -5.33M |
| 1.56 | |
| -2.26 | |
| n/a | |
| 0 | |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 0.04 |
| Volume | 160,086 |
| Avg. Volume (20D) | 26,403 |
| Open | 0.06 |
| Previous Close | n/a |
| Day's Range | 0.03 - 0.06 |
| 52-Week Range | n/a - 0.64 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About LIPO
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrol...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 20, 2022
Employees 5
Stock Exchange OTC Markets OTCPK
Ticker Symbol LIPO
Website https://lipella.com
Financial Performance
In 2024, Lipella Pharmaceuticals's revenue was 536.36K, an increase of 19.29% compared to the previous year's 449.62K. Earnings were -5.02M, an increase of 8.6%.
Financial StatementsEarnings Surprise
Lipella Pharmaceuticals has released their quarterly earnings on Mar 28, 2025:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -1.19 exceeds estimates by 1.24, with -Infinity% YoY decline.